{
  "success": true,
  "pagesUsed": [
    3,
    5,
    8,
    15,
    16,
    17,
    18,
    20,
    21,
    22
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "PROTOCOL SUMMARY",
        "text": "PROTOCOL SUMMARY",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "PROTOCOL SUMMARY",
        "sectionType": {
          "id": "f0f3c9db-8067-4d43-92ad-2a0a9aa093de",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_1_1",
          "nci_1_2",
          "nci_1_3"
        ]
      },
      {
        "id": "nc_2",
        "name": "INTRODUCTION",
        "text": "INTRODUCTION",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "INTRODUCTION",
        "sectionType": {
          "id": "75843a20-af87-438e-b8bb-78d524d6e275",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2",
          "nci_2_3"
        ]
      },
      {
        "id": "nc_3",
        "name": "OBJECTIVES AND ENDPOINTS",
        "text": "OBJECTIVES AND ENDPOINTS",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "OBJECTIVES AND ENDPOINTS",
        "sectionType": {
          "id": "7b3cb21d-f741-4e88-ac1f-fe6c3af82fdf",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_4",
        "name": "STUDY DESIGN",
        "text": "STUDY DESIGN",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "STUDY DESIGN",
        "sectionType": {
          "id": "c156d4f8-863c-4d7f-9344-ea15daae0f4a",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2"
        ]
      },
      {
        "id": "nc_5",
        "name": "STUDY POPULATION",
        "text": "STUDY POPULATION",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "STUDY POPULATION",
        "sectionType": {
          "id": "d2a1403e-98d6-4a2a-b955-34acd20ec6ce",
          "code": "Study Population",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Population",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1",
          "nci_5_2",
          "nci_5_3",
          "nci_5_4"
        ]
      },
      {
        "id": "nc_6",
        "name": "STUDY INTERVENTION",
        "text": "STUDY INTERVENTION",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "6",
        "sectionTitle": "STUDY INTERVENTION",
        "sectionType": {
          "id": "900a599c-4f66-4df2-9397-e861d0471a38",
          "code": "Treatment",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_6_1",
          "nci_6_2",
          "nci_6_3",
          "nci_6_4",
          "nci_6_5"
        ]
      },
      {
        "id": "nc_7",
        "name": "STUDY ASSESSMENTS AND PROCEDURES",
        "text": "STUDY ASSESSMENTS AND PROCEDURES",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "8",
        "sectionTitle": "STUDY ASSESSMENTS AND PROCEDURES",
        "sectionType": {
          "id": "dbba3aca-9e5d-4787-81f0-19c47e1b4563",
          "code": "Study Procedures",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Procedures",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_7_1",
          "nci_7_2",
          "nci_7_3",
          "nci_7_4"
        ]
      },
      {
        "id": "nc_8",
        "name": "STATISTICAL CONSIDERATIONS",
        "text": "STATISTICAL CONSIDERATIONS",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "9",
        "sectionTitle": "STATISTICAL CONSIDERATIONS",
        "sectionType": {
          "id": "61266d3c-86ac-4dd7-afb3-5537a7a1a97f",
          "code": "Statistics",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Statistics",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_8_1",
          "nci_8_2",
          "nci_8_3",
          "nci_8_4"
        ]
      },
      {
        "id": "nc_9",
        "name": "Regulatory, Ethical, and Study Oversight Considerations",
        "text": "Regulatory, Ethical, and Study Oversight Considerations",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix A",
        "sectionTitle": "Regulatory, Ethical, and Study Oversight Considerations",
        "sectionType": {
          "id": "3c4882ea-9d8a-453e-8328-ebcd67bec230",
          "code": "Ethics",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Ethics",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_10",
        "name": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
        "text": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
        "order": 9,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix B",
        "sectionTitle": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
        "sectionType": {
          "id": "7778e1ca-3b09-4144-9a78-e9f3d939ab73",
          "code": "Safety",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Safety",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_11",
        "name": "Abbreviations",
        "text": "Abbreviations",
        "order": 10,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix E",
        "sectionTitle": "Abbreviations",
        "sectionType": {
          "id": "f66052c5-70f4-4c15-807a-592a7fab38ed",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_12",
        "name": "Amendment History",
        "text": "Amendment History",
        "order": 11,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix I",
        "sectionTitle": "Amendment History",
        "sectionType": {
          "id": "9ecc7017-e702-4091-956d-d33e833c91ad",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_1_1",
        "name": "Synopsis",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Synopsis"
      },
      {
        "id": "nci_1_2",
        "name": "Schema",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "Schema"
      },
      {
        "id": "nci_1_3",
        "name": "Schedule of Activities",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "Schedule of Activities"
      },
      {
        "id": "nci_2_1",
        "name": "Study Rationale",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "Study Rationale"
      },
      {
        "id": "nci_2_2",
        "name": "Background",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Background"
      },
      {
        "id": "nci_2_3",
        "name": "Benefit/Risk Assessment",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3",
        "sectionTitle": "Benefit/Risk Assessment"
      },
      {
        "id": "nci_4_1",
        "name": "Overall Design",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1",
        "sectionTitle": "Overall Design"
      },
      {
        "id": "nci_4_2",
        "name": "End of Study Definition",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.4",
        "sectionTitle": "End of Study Definition"
      },
      {
        "id": "nci_5_1",
        "name": "Inclusion Criteria",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "Inclusion Criteria"
      },
      {
        "id": "nci_5_2",
        "name": "Exclusion Criteria",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.2",
        "sectionTitle": "Exclusion Criteria"
      },
      {
        "id": "nci_5_3",
        "name": "Lifestyle Considerations",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.3",
        "sectionTitle": "Lifestyle Considerations"
      },
      {
        "id": "nci_5_4",
        "name": "Screen Failures",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.4",
        "sectionTitle": "Screen Failures"
      },
      {
        "id": "nci_6_1",
        "name": "Investigational Medicinal Products Administered",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.1",
        "sectionTitle": "Investigational Medicinal Products Administered"
      },
      {
        "id": "nci_6_2",
        "name": "Preparation/Handling/Storage/Accountability",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.2",
        "sectionTitle": "Preparation/Handling/Storage/Accountability"
      },
      {
        "id": "nci_6_3",
        "name": "Measures to Minimize Bias: Randomization and Blinding",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.3",
        "sectionTitle": "Measures to Minimize Bias: Randomization and Blinding"
      },
      {
        "id": "nci_6_4",
        "name": "Investigational Medicinal Product Compliance",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.4",
        "sectionTitle": "Investigational Medicinal Product Compliance"
      },
      {
        "id": "nci_6_5",
        "name": "Concomitant Therapy",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.5",
        "sectionTitle": "Concomitant Therapy"
      },
      {
        "id": "nci_7_1",
        "name": "Efficacy Assessments",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "8.1",
        "sectionTitle": "Efficacy Assessments"
      },
      {
        "id": "nci_7_2",
        "name": "Safety Assessments",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "8.2",
        "sectionTitle": "Safety Assessments"
      },
      {
        "id": "nci_7_3",
        "name": "Adverse Events and Serious Adverse Events",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "8.3",
        "sectionTitle": "Adverse Events and Serious Adverse Events"
      },
      {
        "id": "nci_7_4",
        "name": "Pharmacokinetics and Biomarkers",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "8.5",
        "sectionTitle": "Pharmacokinetics and Biomarkers"
      },
      {
        "id": "nci_8_1",
        "name": "Statistical Hypotheses",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.1",
        "sectionTitle": "Statistical Hypotheses"
      },
      {
        "id": "nci_8_2",
        "name": "Sample Size Determination",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.2",
        "sectionTitle": "Sample Size Determination"
      },
      {
        "id": "nci_8_3",
        "name": "Populations for Analysis",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.3",
        "sectionTitle": "Populations for Analysis"
      },
      {
        "id": "nci_8_4",
        "name": "Statistical Analyses",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.4",
        "sectionTitle": "Statistical Analyses"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "IMP",
        "expandedText": "investigational medicinal product",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "CMH",
        "expandedText": "Cochran-Mantel-Haenszel",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "SoA",
        "expandedText": "Schedule of Activities",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "CSP",
        "expandedText": "Clinical Study Protocol",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "ECG",
        "expandedText": "Electrocardiogram",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "SID",
        "expandedText": "Subject Identification",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "SARS-CoV-2",
        "expandedText": "Severe Acute Respiratory Syndrome Coronavirus 2",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "RT-PCR",
        "expandedText": "Reverse Transcription Polymerase Chain Reaction",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "HCP",
        "expandedText": "Healthcare Professional",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "AE",
        "expandedText": "Adverse Event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "SAE",
        "expandedText": "Serious Adverse Event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "AESI",
        "expandedText": "Adverse Event of Special Interest",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "WHO",
        "expandedText": "World Health Organization",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "COVID-19",
        "expandedText": "Coronavirus Disease 2019",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 12,
      "itemCount": 25,
      "abbreviationCount": 14
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study in Adults for the Post-Exposure Prophylaxis and Treatment of COVID-19 (AZD7442)",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "7.0",
      "versionDate": "Not explicitly provided in text",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9",
        "nc_10",
        "nc_11",
        "nc_12"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "IMP",
          "expansion": "investigational medicinal product"
        },
        {
          "abbreviation": "CMH",
          "expansion": "Cochran-Mantel-Haenszel"
        },
        {
          "abbreviation": "SoA",
          "expansion": "Schedule of Activities"
        },
        {
          "abbreviation": "CSP",
          "expansion": "Clinical Study Protocol"
        },
        {
          "abbreviation": "ECG",
          "expansion": "Electrocardiogram"
        },
        {
          "abbreviation": "SID",
          "expansion": "Subject Identification"
        },
        {
          "abbreviation": "SARS-CoV-2",
          "expansion": "Severe Acute Respiratory Syndrome Coronavirus 2"
        },
        {
          "abbreviation": "RT-PCR",
          "expansion": "Reverse Transcription Polymerase Chain Reaction"
        },
        {
          "abbreviation": "HCP",
          "expansion": "Healthcare Professional"
        },
        {
          "abbreviation": "AE",
          "expansion": "Adverse Event"
        },
        {
          "abbreviation": "SAE",
          "expansion": "Serious Adverse Event"
        },
        {
          "abbreviation": "AESI",
          "expansion": "Adverse Event of Special Interest"
        },
        {
          "abbreviation": "WHO",
          "expansion": "World Health Organization"
        },
        {
          "abbreviation": "COVID-19",
          "expansion": "Coronavirus Disease 2019"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study in Adults for the Post-Exposure Prophylaxis and Treatment of COVID-19 (AZD7442)",
        "version": "7.0",
        "versionDate": "Not explicitly provided in text"
      },
      "sections": [
        {
          "number": "1",
          "title": "PROTOCOL SUMMARY",
          "type": "Synopsis",
          "subsections": [
            {
              "number": "1.1",
              "title": "Synopsis"
            },
            {
              "number": "1.2",
              "title": "Schema"
            },
            {
              "number": "1.3",
              "title": "Schedule of Activities"
            }
          ]
        },
        {
          "number": "2",
          "title": "INTRODUCTION",
          "type": "Introduction",
          "subsections": [
            {
              "number": "2.1",
              "title": "Study Rationale"
            },
            {
              "number": "2.2",
              "title": "Background"
            },
            {
              "number": "2.3",
              "title": "Benefit/Risk Assessment",
              "subsections": [
                {
                  "number": "2.3.1",
                  "title": "Risk Assessment"
                },
                {
                  "number": "2.3.2",
                  "title": "Benefit Assessment"
                },
                {
                  "number": "2.3.3",
                  "title": "Overall Benefit:Risk Conclusion"
                }
              ]
            }
          ]
        },
        {
          "number": "3",
          "title": "OBJECTIVES AND ENDPOINTS",
          "type": "Objectives"
        },
        {
          "number": "4",
          "title": "STUDY DESIGN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "4.1",
              "title": "Overall Design"
            },
            {
              "number": "4.4",
              "title": "End of Study Definition"
            }
          ]
        },
        {
          "number": "5",
          "title": "STUDY POPULATION",
          "type": "Study Population",
          "subsections": [
            {
              "number": "5.1",
              "title": "Inclusion Criteria"
            },
            {
              "number": "5.2",
              "title": "Exclusion Criteria"
            },
            {
              "number": "5.3",
              "title": "Lifestyle Considerations"
            },
            {
              "number": "5.4",
              "title": "Screen Failures"
            }
          ]
        },
        {
          "number": "6",
          "title": "STUDY INTERVENTION",
          "type": "Treatment",
          "subsections": [
            {
              "number": "6.1",
              "title": "Investigational Medicinal Products Administered"
            },
            {
              "number": "6.2",
              "title": "Preparation/Handling/Storage/Accountability"
            },
            {
              "number": "6.3",
              "title": "Measures to Minimize Bias: Randomization and Blinding"
            },
            {
              "number": "6.4",
              "title": "Investigational Medicinal Product Compliance"
            },
            {
              "number": "6.5",
              "title": "Concomitant Therapy"
            }
          ]
        },
        {
          "number": "8",
          "title": "STUDY ASSESSMENTS AND PROCEDURES",
          "type": "Study Procedures",
          "subsections": [
            {
              "number": "8.1",
              "title": "Efficacy Assessments"
            },
            {
              "number": "8.2",
              "title": "Safety Assessments"
            },
            {
              "number": "8.3",
              "title": "Adverse Events and Serious Adverse Events"
            },
            {
              "number": "8.5",
              "title": "Pharmacokinetics and Biomarkers"
            }
          ]
        },
        {
          "number": "9",
          "title": "STATISTICAL CONSIDERATIONS",
          "type": "Statistics",
          "subsections": [
            {
              "number": "9.1",
              "title": "Statistical Hypotheses"
            },
            {
              "number": "9.2",
              "title": "Sample Size Determination"
            },
            {
              "number": "9.3",
              "title": "Populations for Analysis"
            },
            {
              "number": "9.4",
              "title": "Statistical Analyses"
            }
          ]
        },
        {
          "number": "Appendix A",
          "title": "Regulatory, Ethical, and Study Oversight Considerations",
          "type": "Ethics"
        },
        {
          "number": "Appendix B",
          "title": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
          "type": "Safety"
        },
        {
          "number": "Appendix E",
          "title": "Abbreviations",
          "type": "Other"
        },
        {
          "number": "Appendix I",
          "title": "Amendment History",
          "type": "Other"
        }
      ]
    }
  }
}